Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Biomolecules|February 25, 2022
Production of Recombinant Alpha-Synuclein: Still No Standardized Protocol in SightMohammed Al-Azzani, Annekatrin König, Tiago Fleming Outeiro
Molecular Neurobiology|January 5, 2022
Endogenous Levels of Alpha-Synuclein Modulate Seeding and Aggregation in Cultured CellsEftychia Vasili, Antonio Dominguez-Meijide, Manuel Flores-León, et al.
European Journal of Medicinal Chemistry|March 1, 2025
Rationally designed peptides inhibit the formation of α-synuclein fibrils and oligomersTariq T Ali, Madiha Merghani, Mohammed Al-Azzani, et al.
NPJ Parkinson'S Disease|October 23, 2025
Glycation of alpha-synuclein enhances aggregation and neuroinflammatory responsesEftychia Vasili, Annekatrin König, Mohammed Al-Azzani, et al.
Journal of Parkinson'S Disease|February 6, 2023
miR-101a-3p Impairs Synaptic Plasticity and Contributes to SynucleinopathyMary Xylaki, Isabel Paiva, Mohammed Al-Azzani, et al.
ACS Chemical Neuroscience|February 26, 2025
Inhibition of the Parkinson's Disease-Related Protein DJ-1 by Endogenous Neurotoxins of the 1,2,3,4-Tetrahydroisoquinoline FamilyCatherine Laurent, Gabrielle Poncet, Tristan Herskovits, et al.
Molecular Neurodegeneration|September 27, 2025
A novel alpha-synuclein G14R missense variant is associated with atypical neuropathological featuresChristof Brücke, Mohammed Al-Azzani, Nagendran Ramalingam, et al.
Medrxiv : the Preprint Server for Health Sciences|October 14, 2024
A novel alpha-synuclein G14R missense variant is associated with atypical neuropathological featuresChristof Brücke, Mohammed Al-Azzani, Nagendran Ramalingam, et al.
Pageof 2